These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3841775)

  • 1. Use of antisecretory drugs for gastroprotection during antiblastic chemotherapy.
    Polloni A; Marchi S; Bellini M; Savalli E; Cecconi N; Vanacore R; Grassi B
    Drugs Exp Clin Res; 1985; 11(4):303-6. PubMed ID: 3841775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirenzepine versus ranitidine in gastroprotection during antiblastic chemotherapy: a double-blind study.
    Polloni A; Marchi S; Martire A; Costa F; Cecconi N; Ruocco L; Maltinti G; Grassi B; Del Tacca M
    Chemioterapia; 1986 Dec; 5(6):420-3. PubMed ID: 3802303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
    Sartori S; Trevisani L; Nielsen I; Tassinari D; Panzini I; Abbasciano V
    J Clin Oncol; 2000 Feb; 18(3):463-7. PubMed ID: 10653861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS; Page MC; Tildesley G; Wood JR
    BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
    Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirenzepine in the treatment of duodenal ulcer. An endoscopically controlled trial.
    Biomed Pharmacother; 1982; 36(5):266-9. PubMed ID: 6762889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive role of pirenzepine in gastric damage during cytostatic therapy. A controlled randomized double-blind study with placebo].
    Contu A; Marenco G; Pani P; Meloni M; Deriu A; Ortu S; Olmeo N; Schintu GM; Daniotti S
    Minerva Dietol Gastroenterol; 1989; 35(4):269-72. PubMed ID: 2695862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience with the use of ranitidine in the prevention of gastroduodenal damage caused by antiblastic polychemotherapy].
    D'Agata A
    Minerva Med; 1998 Oct; 89(10):359-63. PubMed ID: 10189899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical trial on the effect of aluminum containing antacids on the course of duodenal ulcer healing and morphology of the gastric mucosa].
    Mach T
    Folia Med Cracov; 1995; 36(1-4):3-20. PubMed ID: 8834664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminal bicarbonate outflow in chronic antral erosions is suppressed by pirenzepine.
    Guslandi M; Masci E; Ballarin E; Imbimbo BP; Daniotti S
    Hepatogastroenterology; 1987 Aug; 34(4):171-3. PubMed ID: 3666666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
    Michel P; Duhamel C; Bazin B; Raoul JL; Person B; Bigard MA; Legoux JL; Sallerin V; Colin R
    Gastroenterol Clin Biol; 1994; 18(12):1102-5. PubMed ID: 7750682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.